[ad_1] HIGHLIGHTS The US FDA has granted Fast Track Designation to Amplia’s lead drug narmafotinib in advanced pancreatic cancer Fast Track Designation facilitates the development of investigational drugs and allows for expedited review MELBOURNE, Australia, […]
Trending Stories
Halper Sadeh LLC Investigates BTTR, FYBR, GATO, SGRP on Behalf of Shareholders
[ad_1] NEW YORK, Sept. 19, 2024 /PRNewswire/ — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to […]
Navident EVO receives FDA Clearance for Guided Endodontics
[ad_1] TORONTO, Sept. 19, 2024 /PRNewswire/ – ClaroNav Inc, a leader in surgical navigation and photogrammetry systems, is proud to announce that it has received clearance from the U.S. Food and Drug Administration to expand […]
RYBREVANT® (amivantamab-vmjw) plus standard of care approved in the U.S. as first and only targeted regimen to cut risk of disease progression by more than half in second-line EGFR-mutated advanced lung cancer
[ad_1] Approval based on compelling safety and efficacy from the Phase 3 MARIPOSA-2 study, marking the third new indication for RYBREVANT® this year, with four indications overall RARITAN, N.J., Sept. 17, 2024 /PRNewswire/ — Johnson […]
NASA Units Protection for Astronaut Tracy C. Dyson, Crewmates Go back
[ad_1] WASHINGTON, Sept. 19, 2024 /PRNewswire/ — NASA astronaut Tracy C. Dyson, accompanied through Roscosmos cosmonauts Nikolai Chub and Oleg Kononenko, will retirement from the World Dimension Station boarded the Soyuz MS-25 spacecraft, and go back […]
